PepLabo Download

Wegovy® tablets, dehydration and the kidneys

The Wegovy® label carries a warning about sudden kidney injury caused by fluid loss. It applies to the daily tablet as well as the weekly injection, and the tablet trial adds its own figures on how often digestive side effects happened and became severe. This page puts those pieces together for people taking the tablet, with what Europe adds, what else can strain the kidneys and when to get help.

Published · Updated · Wegovy® tablets: side effects by symptom · Written by the PepLabo editorial team

What the tablet trial reported

Neither the US label nor the European information gives a kidney injury figure from the tablet trial. What they do give, from OASIS 4 (Study 7: 204 adults without type 2 diabetes taking the 25 mg tablet for as long as 64 weeks), are the numbers on the digestive reactions that drive fluid loss [1][2][3]. The trial’s registry entry adds its list of serious events [4].

Fluid-related outcomes in the Wegovy® 25 mg tablet trial (OASIS 4)
OutcomePlacebo tabletsWegovy® tablets
Severe gastrointestinal adverse reactions, US label sections 5.6 and 6.1 [1]0%2%
Stopped treatment because of a gastrointestinal reaction, US label section 6.1 [1]2%3.4%
Vomiting, EU SmPC section 4.8 [2]5.9%30.9%
Diarrhoea, EU SmPC section 4.8 [2]8.8%17.6%
Nausea, EU SmPC section 4.8 [2]18.6%46.6%
Acute kidney injury recorded as a serious event, ClinicalTrials.gov [4]1 of 1020 of 204

From stomach upset to the kidneys

Section 5.5 is titled Acute Kidney Injury Due to Volume Depletion. It describes reports, received after semaglutide reached the market, of sudden kidney injury, in some cases severe enough to need hemodialysis. Most of the people affected had stomach side effects such as nausea, vomiting or diarrhea that left them dehydrated [1].

The title names the link: volume depletion, meaning the body has lost more fluid than it has taken back. Europe describes the same chain in plainer words, saying that dehydration from these side effects can, in rare cases, lead to worse kidney function [2]. MedlinePlus lists dehydration among the causes of reduced blood flow to the kidneys that can bring on acute kidney failure [6]. The general guide to the kidney warning on GLP-1 medicines covers the class as a whole.

Data the label applies to both forms

The kidney injury rates in section 6.1 come from the injection’s weight-reduction trials, and the label states that these findings apply to the tablet too: 7 adults on Wegovy® (0.4 cases per 100 patient-years) against 4 on placebo (0.2 per 100 patient-years). Some cases occurred alongside stomach side effects or dehydration [1].

The same paragraph notes two patterns. Kidney-related reactions were more likely in people who already had impaired kidney function, and they happened more often while the dose was being raised [1]. Europe adds that people with moderate impairment may have more stomach side effects in the first place, that experience in severe impairment is limited and that semaglutide is not recommended there [2].

Dose steps and the kidney check

The tablet starts at 1.5 mg once a day. Under Table 2 of the label, it moves to 4 mg on day 31, 9 mg on day 61 and the 25 mg maintenance strength from day 91. The label presents this gradual climb as a way to reduce the risk of digestive side effects [1]. Europe describes the same steps in four-week blocks and allows staying at the previous level if needed [2].

Section 5.5 asks prescribers to check kidney function in people whose side effects could cause fluid loss, especially at the start and during dose increases. Section 2.3 gives prescribers two options if a step is not tolerated: wait longer before the next increase, or, if 25 mg itself is the problem, consider a switch to the injection at 1.7 mg weekly. Which route fits is a decision for your prescriber [1].

The morning dose and your first drink

The tablet has its own routine. It is taken on waking, before food, swallowed whole with a small amount of plain water (the US label sets 4 ounces as the most), and then nothing else is eaten, drunk or swallowed for at least 30 minutes. Section 12.3 explains why: in studies, a longer wait after the dose led to more semaglutide being absorbed [1].

That small sip is limited only around the dose. Nothing in the label restricts fluids for the rest of the day, and the Medication Guide stresses that drinking fluids helps lower your chance of dehydration [1]. Europe’s leaflet makes the same point and says it matters most if you have kidney problems [2]. If you have been sick overnight, the 30-minute window is worth mentioning to your prescriber.

Other things that strain the kidneys

Dehydration has causes beyond the medicine. MedlinePlus lists heavy sweating, fever, vomiting or diarrhea, passing a lot of urine and simply not drinking enough because you feel sick, and notes that older adults and people with diabetes are at higher risk [5].

For acute kidney failure itself, MedlinePlus names very low blood pressure from dehydration or serious illness, kidney infections, a blocked urinary tract and certain medicines, including non-steroidal anti-inflammatory painkillers, some antibiotics and blood pressure medicines and contrast dye [6]. If you take any of these, your prescriber and pharmacist need the full list.

What helps, according to the sources

  • Keep drinking through the day; the Medication Guide says fluids help reduce the chance of dehydration [1].
  • MedlinePlus suggests sipping water or sucking ice cubes, or drinks with electrolytes, and advises against salt tablets [5].
  • Anyone with fever, vomiting or diarrhea should drink plenty without waiting for signs of dehydration, and call a provider early if dehydration seems likely [5].
  • Before starting, tell your provider about any past or current kidney problems, as the Medication Guide asks [1].

Signs worth knowing

  • Mild to moderate dehydration: thirst, a dry or sticky mouth, passing little urine, darker yellow urine, headache and muscle cramps [5].
  • Severe dehydration: no urine or very dark urine, dizziness, a fast heartbeat, fast breathing, confusion or listlessness [5].
  • Possible kidney trouble: little or no urine, swelling in the legs, ankles or feet, fatigue and nausea or vomiting lasting days [6].

Wegovy® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help

SignWho to contactHow fastSource
Loss of consciousness, confusion or a seizure in someone who has been vomiting or has diarrheaEmergency services (911)EmergencyMedlinePlus [5]
Little or no urine, very dark urine or swelling of the legs while unwellYour healthcare provider, the same dayTodayMedlinePlus [5][6]
Nausea, vomiting or diarrhea that does not go awayYour healthcare provider right awayTodayMedication Guide and section 17 [1]
Stomach problems that are severe or do not settleYour healthcare providerTodayMedication Guide [1]
Known kidney disease before starting the tabletYour prescriberAt your next appointmentMedication Guide [1] and EU SmPC [2]

Questions

How often were stomach side effects severe on Wegovy® tablets?

In the label’s tablet trial, severe gastrointestinal adverse reactions were reported by 2% of adults on Wegovy® tablets and by no one on placebo. Digestive reactions led 3.4% on the tablet and 2% on placebo to stop [1].

Did the tablet trial report kidney injury?

Neither label document gives a tablet kidney figure. The registry results list one serious acute kidney injury, in the placebo group. The label’s rates come from injection studies, and it applies them and the section 5.5 warning to the tablet [1][4].

Does the 4-ounce water limit mean drinking less all day?

No. The label limits water only when you swallow the tablet and asks you to wait 30 minutes before other drinks. It sets no limit for the rest of the day, and the Medication Guide says drinking fluids helps reduce the chance of dehydration [1].

I have chronic kidney disease. Can I take Wegovy® tablets?

Europe does not recommend semaglutide in severe kidney impairment and notes more stomach side effects with moderate impairment; the US label says kidney reactions were more likely with prior impairment. Your prescriber decides [1][2].

I vomited soon after taking my tablet. Should I take another?

The label does not address vomiting after a dose. It does say not to take more than one tablet a day, so ask your prescriber or pharmacist rather than repeating the dose [1].

Can painkillers add to the kidney risk?

MedlinePlus lists non-steroidal anti-inflammatory drugs among medicines that can cause acute kidney failure. The Wegovy® label asks you to tell your provider about all medicines you take, including over-the-counter ones [1][6].

Set up your lab tonight.

It takes a few minutes. Pep will be waiting.